Professor, Department of Obstetrics and Gynaecology ; Deputy Director, Prenatal Genetic Diagnosis Centre, CUHK; Director, Pre-implantation Genetic Diagnosis Laboratory, CUHK
BIOGRAPHY
Event Date & Time
Date: April 22, 2021
Time: 10:00am (CEST), 4:00pm (CST)
Abstract
Advancements in technologies have revolutionized the genetic landscape. Chromosomal microarray analysis (CMA) becomes a proven method and is implemented to detect gains and losses of DNA and absence of heterozygosity across the genome. Next-generation sequencing technologies have brought opportunities and challenges to genetic testing, its prenatal application is an emerging field. We describe our experience using FetalChip, a CMA for prenatal research developed in our laboratory and describe the role of CMA in the era of genome sequencing.
Learning Objectives
- The role of chromosomal microarray analysis (CMA) in prenatal genetic clinical research.
- CMA is a well-established and proven technology to identify pathogenic CNVs
- The utility of genome sequencing
For Research Use Only. Not for use in diagnostic procedures.
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...